TR200102009T2 - The use of compounds according to formula I for prophylaxis and treatment of cerebral process - Google Patents

The use of compounds according to formula I for prophylaxis and treatment of cerebral process

Info

Publication number
TR200102009T2
TR200102009T2 TR2001/02009T TR200102009T TR200102009T2 TR 200102009 T2 TR200102009 T2 TR 200102009T2 TR 2001/02009 T TR2001/02009 T TR 2001/02009T TR 200102009 T TR200102009 T TR 200102009T TR 200102009 T2 TR200102009 T2 TR 200102009T2
Authority
TR
Turkey
Prior art keywords
formula
cerebral
treatment
prophylaxis
compounds according
Prior art date
Application number
TR2001/02009T
Other languages
Turkish (tr)
Inventor
Steiner Gerd
Schellhaas Kurt
Lubisch Wilfried
Holzenkamp Uta
Starck Dorothea
Szabo Laszlo
Emling Franz
Javier Garcia-Ladona Francisco
Hofmann Hans-Peter
Unger Liliane
Original Assignee
Basf Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag. filed Critical Basf Ag.
Publication of TR200102009T2 publication Critical patent/TR200102009T2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

Serebral islemin ve felcin önlenmesi ve tedavi edilmesi için ilaçlar hazirlamak amaciyla, degiskenlerin açiklama içerisinde tanimlanmis oldugu formül I'in bilesiklerinin ve farmakolojik olarak kabul edilen tuzlarinin kullanilmasi tarif edilmektedir. (Formül I).In order to prepare drugs for the prevention and treatment of cerebral process and stroke, the use of the compounds of formula I and the pharmacologically acceptable salts of the variables are described. (Formula I).

TR2001/02009T 1999-01-11 1999-12-22 The use of compounds according to formula I for prophylaxis and treatment of cerebral process TR200102009T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19900544A DE19900544A1 (en) 1999-01-11 1999-01-11 Use of compounds of formula I for the prophylaxis and therapy of cerebral ischemia

Publications (1)

Publication Number Publication Date
TR200102009T2 true TR200102009T2 (en) 2002-01-21

Family

ID=7893835

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/02009T TR200102009T2 (en) 1999-01-11 1999-12-22 The use of compounds according to formula I for prophylaxis and treatment of cerebral process

Country Status (19)

Country Link
EP (1) EP1140099A1 (en)
JP (1) JP2002534467A (en)
KR (1) KR20010101440A (en)
CN (1) CN1333685A (en)
AR (1) AR029741A1 (en)
AU (1) AU2285100A (en)
BG (1) BG105688A (en)
BR (1) BR9916888A (en)
CA (1) CA2359390A1 (en)
DE (1) DE19900544A1 (en)
HU (1) HUP0200520A3 (en)
IL (1) IL144145A0 (en)
MX (1) MXPA01006966A (en)
NO (1) NO20013408L (en)
PL (1) PL348916A1 (en)
SK (1) SK9682001A3 (en)
TR (1) TR200102009T2 (en)
WO (1) WO2000041697A1 (en)
ZA (1) ZA200105473B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7618959B2 (en) 2002-11-05 2009-11-17 Smithklinebeecham Corp Antibacterial agents
CN1856475A (en) * 2003-09-23 2006-11-01 默克公司 Isoquinoline potassium channel inhibitors
EP1939189A4 (en) * 2005-08-26 2013-03-13 Shionogi & Co Derivative having ppar agonistic activity
EA201000516A1 (en) * 2007-09-20 2010-10-29 Кортекс Фармасеутикалс, Инк. 3-SUBSTITUTED 1,2,3-TRIAZIN-4-ONE and 3-SUBSTITUTE 1,3-Pyrimidine-ONE TO STRENGTHEN GLUTAMATERGIC SYNAPTIC RESPONSES
MA41168A (en) * 2014-12-17 2017-10-24 Acraf NEW ANTIBACTERIAL COMPOUNDS
CN108484594B (en) * 2018-02-09 2020-08-04 福建医科大学 Alkoxy substituted tetrahydropyridopyrimidine compound or available salt thereof, and preparation method and application thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3620643A1 (en) * 1985-06-22 1987-01-22 Sandoz Ag Thiazoles, their preparation and use
DE3831888A1 (en) * 1988-09-20 1990-03-29 Troponwerke Gmbh & Co Kg MEDICINES FOR TREATING APOPLEXIA CEREBRI
JP3036789B2 (en) * 1990-06-22 2000-04-24 三井化学株式会社 Novel heterocyclic compounds and pharmaceutical compositions
DE19746612A1 (en) * 1997-10-22 1999-04-29 Basf Ag New 2-substituted 1,2-benzisothiazole derivatives
DE19747063A1 (en) * 1997-10-24 1999-04-29 Basf Ag New 3-substituted tetrahydropyridopyrimidinone derivatives

Also Published As

Publication number Publication date
AR029741A1 (en) 2003-07-16
AU2285100A (en) 2000-08-01
SK9682001A3 (en) 2002-03-05
CA2359390A1 (en) 2000-07-20
BG105688A (en) 2002-02-28
NO20013408L (en) 2001-08-21
HUP0200520A3 (en) 2003-04-28
BR9916888A (en) 2001-11-20
WO2000041697A1 (en) 2000-07-20
CN1333685A (en) 2002-01-30
JP2002534467A (en) 2002-10-15
MXPA01006966A (en) 2002-04-10
ZA200105473B (en) 2002-10-03
DE19900544A1 (en) 2000-07-13
IL144145A0 (en) 2002-05-23
HUP0200520A2 (en) 2002-07-29
KR20010101440A (en) 2001-11-14
EP1140099A1 (en) 2001-10-10
NO20013408D0 (en) 2001-07-10
PL348916A1 (en) 2002-06-17

Similar Documents

Publication Publication Date Title
GB0005251D0 (en) Therapeutic compounds
TW200518753A (en) Pyridylpiperazines and aminonicotinamides and their use as therapeutic agents
TNSN06032A1 (en) Pyridazine derivatives and their use as therapeutic agents
GB0225475D0 (en) Therapeutic agents
GB0225474D0 (en) Therapeutic agents
MY135841A (en) Novel benzodioxoles
GB0223038D0 (en) Therapeutic compounds
TR200200579T2 (en) Amino-thyrazolpyridine derivatives.
GB0025173D0 (en) Therapeutic agents
ATE248837T1 (en) QUINUCLIDINE-ACRYLAMIDE
DE60316779D1 (en) THIADIAZOLYLPIPERAZINE DERIVATIVES SUITABLE FOR THE TREATMENT OF BZW. PREVENTION OF PAIN
AU2002225772A1 (en) Therapeutic agents and methods of use thereof for treating an amyloidogenic disease
BR0109703A (en) Piperazine Derivatives
MXPA04012965A (en) Viral inhibitors.
BG101118A (en) Therapeutical compounds
ATE402176T1 (en) PYRROLIDINE AND AZETIDINE COMPOUNDS ALSCCR5 ANTAGONISTS
ZA967746B (en) Treatment of tinnitus using neuroprotective agents.
AP2002002664A0 (en) Cyclohexylamine derivative as subtype selective NMDA receptor antagonists.
TR199802060T2 (en) Use of aminoisoquinolins and aminopyridine derivatives as anti-inflammatory agents.
SE9802208D0 (en) Novel compounds
PT992509E (en) NEW MACROLIDED DERIVATIVES
BR9503572A (en) Compound pharmaceutical composition and method of treatment or prevention of a disease
TR200102008T2 (en) Use of pyridine derivatives for prophylaxis and treatment of cerebral ischemia.
ATE319473T1 (en) MELAGATRAN FOR THE TREATMENT OF INFLAMMATION
ATE360428T1 (en) ANALGESIC MEDICINAL PRODUCT